Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor.
Dematteo
Ronald P
RP
Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Maki
Robert G
RG
Antonescu
Cristina
C
Brennan
Murray F
MF
D001549:Benzamides; D001707:Biopsy, Needle; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000379:methods*; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D009367:Neoplasm Staging; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000556:secondary; D010879:Piperazines / Q000008:administration & dosage* / Q000009:adverse effects; D011379:Prognosis; D011743:Pyrimidines / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012680:Sensitivity and Specificity; D017154:Stromal Cells / Q000473:pathology*; D016019:Survival Analysis; D016896:Treatment Outcome
D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate